The Italian neuromodulation startup Newronika has secured a European approval for its closed-loop, adaptive implant for ...
Medical Device Network on MSN8d
FDA tags Medtronic embolisation device recall as Class IThe US Food and Drug Administration (FDA) has tagged Medtronic’s recall of certain Pipeline Vantage embolisation devices as ...
The FDA recall affects more than 25,000 of the Fridley-run company’s devices and follows reports of 17 injuries.
The brain implants market is projected to grow from US$ 7.21 billion in 2022 to US$ 17.65 billion by 2030, at a CAGR of 11.8% ...
Medtronic plc (NYSE:MDT – Get Free Report) has received a consensus rating of “Hold” from the sixteen ratings firms that are ...
In 2022, the brain implants market was valued at over USD 5.7 billion, and its rapid expansion is fueled by several key factors. One of the most significant drivers is the rising incidence of nervous ...
Spinal cord stimulators have grown in popularity over the past several years as patients see benefits in the less-invasive ...
Several spine and orthopedic companies have made progress with acquisitions in the first quarter of 2025. 1. Stryker has ...
Medtronic plc (NYSE:MDT – Get Free Report ... Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy ...
Medtronic’s revised instructions for Pipeline ... This month, Philips pulled its endovascular implant from the market after the device was hit with a Class I recall tag from the FDA.
Twenty-eight years later, as a political science professor emeritus at Stanford, Krehbiel just became the first person in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback